Join
Live feed
·
INSIDERFilingvia Quantisnow
The Pennant Group Inc. logo

Chief Clinical Officer Steik Jason Paul sold $53,700 worth of shares (1,394 units at $38.52), decreasing direct ownership by 8% to 15,106 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PNTG (The Pennant Group Inc.) and more on Quantisnow.